Molmiru
Category: AI in Biotech / Drug Discovery
AI molecular visualization platform aimed at accelerating drug discovery. Latest round: Series A. Key investors include ["Mitsubishi UFJ Capital"].
Value proposition
Molmiru’s AI molecular visualization platform enables researchers to interact with and analyze molecular structures more efficiently, accelerating drug discovery.
Products and solutions
["AI molecular visualization platform"]
Industries served
["Biotech","Drug Discovery"]
Technology advantage
Its AI-driven molecular visualization platform offers domain-specific modeling for biotech, leveraging early-stage Japanese venture interest and corporate venture backing.
Market positioning
AI drug discovery tooling startup targeting pharmaceutical and biotech companies in the nascent Japanese biotech AI ecosystem.